Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(4-Phenoxyphenyl)piperazine → 5-[4-(4-(4-Phenoxyphenyl)piperazin-1-yl)butyryl]2,3,4,5-tetrahydro-1,5-benzoxazepine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(4-Phenoxyphenyl)piperazine | HCID 3017356 | — |
| 반응물 | 5-(4-Chlorobutyryl)-2,3,4,5-tetrahydro-1,5-benzoxazepine | HCID 19694250 | — |
| 생성물 | 5-[4-(4-(4-Phenoxyphenyl)piperazin-1-yl)butyryl]2,3,4,5-tetrahydro-1,5-benzoxazepine | HCID 19694232 | — |
반응 단계
The compound (16) synthesized in Reference Example 16 and 1-(4-phenoxylphenyl)piperazine [DE 2631885] were used to produce the above compound in the same way as Example 1.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05723475 |
| 출처 데이터셋 | uspto-grants-1998_03 |
| ORD ID | ord-e55b92dd5753463f9e20cccc10543c7b |
| 출처 메모 | uspto-grants-1998_03 |